Pola Penggunaan Kombinasi CCB–ACEI dan Diuretik–ARB Terhadap Karakteristik Pasien Gagal Ginjal Kronik

Authors

  • Putri Sabrina Mawarda Universitas Muhammadiyah Kudus
  • Eko Retnowati Universitas Muhammadiyah Kudus
  • Intan Adevia Rosnarita Universitas Muhammadiyah Kudus

DOI:

https://doi.org/10.31004/joecy.v6i1.9893

Keywords:

chronic kidney disease, hypertension, CCB–ACEI, Diuretic–ARB

Abstract

 

Chronic kidney disease (CKD) is a progressive condition frequently accompanied by hypertension, making the selection of appropriate antihypertensive combinations crucial for maintaining hemodynamic stability and preventing further deterioration of renal function. This study aimed to describe the characteristics of CKD patients, the pattern of antihypertensive combination use, and to analyze the relationship between age and the selection of CCB–ACEI or Diuretic–ARB therapy among hospitalized patients. This research employed an analytical observational design with a retrospective cross-sectional approach involving 81 patients aged 17–85 years. The results showed that most patients were in the 47–61-year age group (60.5%), consistent with age-related physiological changes that increase renal vulnerability to damage. The most frequently used antihypertensive combination was Diuretic–ARB (80.2%), with Spironolactone–Candesartan being the most common regimen, reflecting the clinical need to manage fluid retention in CKD patients. Meanwhile, CCB–ACEI combinations were used by 19.8% of patients, predominantly Ramipril–Amlodipine and Ramipril–Nicardipine. The variation in regimens illustrates therapeutic adjustments based on individual clinical conditions, including fluid status, renal function, comorbidities, and drug tolerance. Statistical analysis demonstrated a significant relationship between age and the type of antihypertensive combination used (p = 0.037), where patients aged 47–61 years more frequently received CCB–ACEI, while Diuretic–ARB dominated other age groups due to differing hemodynamic needs. In conclusion, the selection of antihypertensive combinations in CKD patients is strongly influenced by age and individual clinical status, highlighting the need for personalized therapeutic approaches to achieve optimal management.

 

References

Anggi et al. (2023). Profil dan Rasionalitas Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Di Fasilitas Kesehatan Tingkat Pertama Periode Mei - Juli 2021. Majalah Farmaseutik, 19(1), 1. https://doi.org/10.22146/farmaseutik.v19i1.80153

Apridelia Natasya Putri et.al. (2022). Jurnal keperawatan tropis papua Hubungan pengetahuan cara mengurangi rasa haus dengan kenaikan berat badan interdialitik pasien penyakit ginjal kronik yang menjalani hemodialisis. 05(2023), 3–8.

Auliafendri, N., & Khairiati, R. (2022). Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Gagal Ginjal Kronik (Ggk) Di Unit Hemodialisa Rsu Imelda Pekerja Indonesia Medan. JIFI (Jurnal Ilmiah Farmasi Imelda), 6(1), 22–29. https://doi.org/10.52943/jifarmasi.v6i1.1116

Basir, 2020. (2020). Evaluasi penggunaan obat antihipertensi pada pasien hipertensi dengan gagal ginjal kronik rawat jalan di rumah sakit “x” makassar tahun 2019. 4(1), 22–27.

Browne, 2024. (2024). Prevalence , awareness , treatment , and control of hypertension in community-dwelling older adults with chronic kidney disease : the Irish longitudinal study on ageing. Clinical Kidney Journal, 17(8), 1–10. https://doi.org/10.1093/ckj/sfae184

Cristian, Siagian Et Al., 2025. (2025). Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Penyakit Gagal Ginjal Kronik Di Rawat Inap Rs X Di Tangerang Evaluation Of The Use Of Antihypertensive Drugs In Chronic Kidney Disease Patients At The X In Tangerang Hospital. 8(1), 1–12.

Eka Fitri Ayu Lestari, 2021. (2021). Evaluasi Efektivitas Antihipertensi Pada Pasien Hipertensi Dengan Gagal Ginjal Kronis Di Rawat Inap Rsud Kota Madiun. Duta Pharma Journal, 1(2), 25–31. https://doi.org/10.47701/djp.v1i2.1217

Eva et al. (2024). Perbandingan Efektivitas Obat Antihipertensi Golongan ARB versus CCB terhadap Penurunan Tekanan Darah pada Pasien Hipertensi Medula I Volume 14 I Nomor 4 I.

Harun, H., Dewi, A. F., & Amelia, R. (2024). The correlation between pentraxin-3, matrix metalloproteinase-9, and estimated glomerular filtration rate in patients with chronic kidney disease. Jurnal Kedokteran Dan Kesehatan Indonesia, 60–69. https://doi.org/10.20885/jkki.vol15.iss1.art8

Joseph, 2018. (2018). Pharmacological reversal of the direct oral anticoagulants — A comprehensive review of the literature. January, 251–265. https://doi.org/10.1002/rth2.12089

Kdigo, 2024. (2024). Kdigo 2024 Clinical Practice Guideline For The Evaluation And Management. 105(4).

Nuryanti, E., Wardhana, M. F., & Damayanti, E. (2024). Perbandingan Nuryanti, E., Wardhana, M. F., & Damayanti, E. (2024). Perbandingan Efektivitas Obat Antihipertensi Golongan ARB versus CCB terhadap Penurunan Tekanan Darah pada Pasien Hipertensi. Medical Profession Journal of Lampung, 14(4), 712–718.Efektiv. Medical Profession Journal of Lampung, 14(4), 712–718.

Orlando, 2019. (2019). Origin and Evolution of Deleterious Mutations.

Padilah, AlfikaL, & Linmus. (2024). Musyawarah Masyarakat Desa (MMD I dan MMD II) Serta Implementasi Praktif Profesi Kepreawatan KOmunitas di RW 10 RT 01-06 Kecamatan Priuk KOta Tangerang. Ilmu Kesehatan, 4(1), 1–6. https://doi.org/10.5455/mnj.v1i2.644xa

Putra et al. (2023). Profil Obat Antihipertensi Pada Pasien Hipertensi Dengan Penyakit Ginjal Kronis. JPS : Journal Of Pharmaceutical And Sciences, 6(4), 1912–1918.

Ramadhian, Ricky, M., & Pahmi, K. (2021). Aktivitas diuresis leucaena leucocephala. Journal Syifa Sciences & Clinical Research, 3(1), 32–38.

Retnowati, 2025. (2025). Upskilling and Reskilling Non-Communicable Disease Cadres for Increasing Chronic Disease Management 56 ) Upskilling and Reskilling Non-Communicable Disease Cadres for Increasing Chronic Disease Management , Lestari , D . T ., Retnowati , E ., Aman , S . 55–62.

Rosnarita, (2025). (2023). Jurnal Inovasi Kesehatan Adaptif. SENTRI: Jurnal Riset Ilmiah, 5(36), 71–85. Hubungan Profil Pasien Gagal Jantung terhadap Efektivitas Terapi Kombinasi Antihipertensi di Rawat Inap RSUD dr. Loekmono Hadi Kudus

Sugiarto, H., Maulia Fitrianti, A., Wahyuni, S., & Musta’in, M. (2024). Tingkat Kepatuhan dan Kualitas Hidup Pasien Gagal Ginjal Kronik yang Menjalani Hemodialisa. Jurnal Keperawatan Berbudaya Sehat, 2(2), 52–56. https://doi.org/10.35473/jkbs.v2i2.3241

Ulfa, 2019. (2019). Profil Penggunaan Obat Antianemia , Antihipertensi , dan Antidiabetik pada Pasien Penyakit Ginjal Kronik di Salah Satu Rumah Sakit Wilayah Surabaya Selatan Drug Utilization Profile of Antianemic , Antihypertensive , and Antidiabetic in Patients with Chron. 16(02), 296–306.

Yusra et al. (2023). Peranan ACE-Inhibitor pada penyakit jantung bawaan. Sasambo Journal of Pharmacy, 4(2), 69–76. https://doi.org/10.29303/sjp.v4i2.240

Zhang, 2019. (2019). Electrical Conduction System Remodeling in Streptozotocin-Induced Diabetes Mellitus Rat Heart. 10(July), 1–15. https://doi.org/10.3389/fphys.2019.00826

Downloads

Published

16-04-2026

How to Cite

Mawarda, P. S., Retnowati, E., & Rosnarita, I. A. . (2026). Pola Penggunaan Kombinasi CCB–ACEI dan Diuretik–ARB Terhadap Karakteristik Pasien Gagal Ginjal Kronik. Journal of Innovative and Creativity, 6(1), 21541–21546. https://doi.org/10.31004/joecy.v6i1.9893

Issue

Section

Articles